Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.

Paikin JS, Wright DS, Crowther MA, Mehta SR, Eikelboom JW.

Circulation. 2010 May 11;121(18):2067-70. doi: 10.1161/CIRCULATIONAHA.109.924944. Review. No abstract available.

2.

Antithrombotic therapy during and after percutaneous coronary intervention in patients with atrial fibrillation.

Verheugt FW.

Circulation. 2013 Oct 29;128(18):2058-61. doi: 10.1161/CIRCULATIONAHA.113.002250. Review. No abstract available.

3.

Atrial fibrillation and coronary artery disease: which antithrombotic treatment strategy?

Lamberts M, Dewilde W, Hansen ML.

Curr Opin Cardiol. 2014 Nov;29(6):595-600. doi: 10.1097/HCO.0000000000000106. Review.

PMID:
25159278
4.

Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.

Helft G, Gilard M, Le Feuvre C, Zaman AG.

Nat Clin Pract Cardiovasc Med. 2006 Dec;3(12):673-80. Review.

PMID:
17122800
5.

Dual antiplatelet therapy in coronary artery disease: a case-based approach.

Raymond C, Menon V.

Cleve Clin J Med. 2009 Nov;76(11):663-70. doi: 10.3949/ccjm.76a.09045. Review.

PMID:
19884296
6.

Triple antithrombotic management after stent implantation: when and how?

Schömig A, Sarafoff N, Seyfarth M.

Heart. 2009 Aug;95(15):1280-5. doi: 10.1136/hrt.2008.160457. Review. No abstract available.

PMID:
19605755
7.

Overview of therapies for prevention of restenosis after coronary interventions.

Garas SM, Huber P, Scott NA.

Pharmacol Ther. 2001 Nov-Dec;92(2-3):165-78. Review.

PMID:
11916536
8.

[Stents in interventional cardiology].

Grinius V, Navickas R, Unikas R.

Medicina (Kaunas). 2007;43(3):183-9. Review. Lithuanian.

9.
10.

[Which antithrombotic treatment in case of atrial fibrillation and coronary heart disease?].

Fauchier L, Taillandier S, Clementy N.

Rev Prat. 2013 Feb;63(2):200. Review. French. No abstract available.

PMID:
23513781
11.

Antithrombotic therapy for coronary artery disease and valvular heart disease.

Israel DH, Fuster V, Chesebro JH, Badimon L.

Baillieres Clin Haematol. 1990 Jul;3(3):705-43. Review. No abstract available.

PMID:
2271788
12.

Fibrinolytic therapy in coronary artery disease.

Gill JB, Massel D, Cairns J.

Baillieres Clin Haematol. 1990 Jul;3(3):745-79. Review. No abstract available.

PMID:
2271789
13.

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.

Bryniarski L, Pelc-Nowicka A, Zabojszcz M, Mirek-Bryniarska E.

Cardiol J. 2009;16(2):179-89. Review.

14.

Advances in cardiovascular therapy.

Houghton JL.

J Med Assoc Ga. 1992 Feb;81(2):69-74. Review. No abstract available.

PMID:
1556506
16.

Optimal therapy for degenerated saphenous vein graft disease.

Kramer B.

J Invasive Cardiol. 1995;7 Suppl D:14D-20D. Review. No abstract available.

PMID:
10155126
17.

Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.

Bhatt DL.

Am J Cardiol. 2009 Feb 2;103(3 Suppl):11A-19A. doi: 10.1016/j.amjcard.2008.11.018. Review.

PMID:
19166708
18.

Primary angioplasty for acute myocardial infarction.

Gordon PC.

Med Health R I. 2001 Feb;84(2):44-50. Review. No abstract available.

PMID:
11272659
19.

[Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].

Syvänne M.

Duodecim. 1999;115(10):1167-73. Review. Finnish. No abstract available.

PMID:
11877856
20.

[Antithrombotic therapy in coronary intervention: angioplasty and coronary bypass surgery].

Kornowski R, Schwartz D, Aderka D, Levo Y.

Harefuah. 1991 Jul;121(1-2):51-4. Review. Hebrew. No abstract available.

PMID:
1748346

Supplemental Content

Support Center